Обзор
Bioverge is a US-based venture capital firm providing equity funding to early-stage life sciences and biotechnology companies at the pre-seed and seed stages. Led by General Partner Rick Gibb, the firm focuses on investing in innovative biotech ventures during their earliest funding rounds.
